For in-depth information on divisions, physician publications and bios, current fellows, research activities and financials, please see our Academic Annual Reports.
Immunology: David Rawlings, MD, Hans Ochs, MD and Andrew Scharenberg, MD have developed a major program unraveling the genetic basis of immune deficiency disorders in children. Studies leading to specific gene therapies are already underway.
Cystic Fibrosis Research: The Cystic Fibrosis Research team, headed by Bonnie Ramsey, MD, performed the trials leading to a novel method of delivering the antibiotic, Tobramycin, to the lungs of children and adults with cystic fibrosis. This therapy is now standard treatment throughout the world. The group is now focusing on the genetic and cellular pathogenesis of the bacteria infecting CF patients with the hopes of reducing lung infections.
Childhood Injury Prevention: Faculty in the Department of Pediatrics have provided national leadership in the study of childhood injuries and in the methods of reducing these injuries. Major local and national injury prevention interventions have resulted in the areas of bicycle helmet use, water safety, gun safety and seat-belt use.